Top Five Gaining Stocks Review: NASDAQ:SNTS, NASDAQ:HALO, NASDAQ:OLED, NASDAQ:SQNM, NASDAQ:HZNP

New York, NY -- (SBWIRE) -- 11/08/2013 -- Santarus, Inc. (NASDAQ:SNTS) reported EPS of 1.435. For the Current Fiscal year, the company is expected to report EPS of 1.28. For the Next Quarter and Next Year, the company is expected to report EPS of 0.32 and 1.41 respectively. At Current Market Price, SNTS is in distance of +39.92% from its 50-day Moving Average price of $22.8703 and +41.48% from its 200-day Moving Average price of $22.6175. Santarus, Inc., a specialty biopharmaceutical company, focuses on acquiring, developing, and commercializing proprietary products that address the needs of patients treated by physician specialists.